Cargando…
Expression of Bmi-1 is a prognostic marker in bladder cancer
BACKGROUND: The molecular mechanisms of the development and progression of bladder cancer are poorly understood. The objective of this study was to analyze the expression of Bmi-1 protein and its clinical significance in human bladder cancer. METHODS: We examined the expression of Bmi-1 mRNA and Bmi...
Autores principales: | Qin, Zi-Ke, Yang, Jian-An, Ye, Yun-lin, Zhang, Xing, Xu, Li-Hua, Zhou, Fang-Jian, Han, Hui, Liu, Zuo-Wei, Song, Li-Bing, Zeng, Mu-Sheng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652492/ https://www.ncbi.nlm.nih.gov/pubmed/19228380 http://dx.doi.org/10.1186/1471-2407-9-61 |
Ejemplares similares
-
Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010) -
Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer
por: Li, Ye-Ping, et al.
Publicado: (2018) -
Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells
por: LIU, ZHI-GANG, et al.
Publicado: (2011) -
BMI1 activates P-glycoprotein via transcription repression of miR-3682-3p and enhances chemoresistance of bladder cancer cell
por: Chen, Ming-Kun, et al.
Publicado: (2021) -
Prognostic significance of combined pretreatment body mass index (BMI) and BMI loss in patients with esophageal cancer
por: Gu, Wen-Shen, et al.
Publicado: (2019)